Low endogenous glucocorticoid allows induction of kidney cortical cyclooxygenase-2 during postnatal rat development.
D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2 / Q000235:genetics / Q000378:metabolism; D000450:Aldosterone / Q000097:blood; D000818:Animals; D003345:Corticosterone / Q000097:blood* / Q000494:pharmacology; D051546:Cyclooxygenase 2; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000502:physiology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000502:physiology; D005938:Glucocorticoids / Q000494:pharmacology; D007527:Isoenzymes / Q000235:genetics* / Q000378:metabolism*; D007672:Kidney Cortex / Q000201:enzymology* / Q000254:growth & development*; D007679:Kidney Medulla / Q000201:enzymology / Q000254:growth & development; D008138:Loop of Henle / Q000201:enzymology / Q000254:growth & development; D011451:Prostaglandin-Endoperoxide Synthases / Q000235:genetics* / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D011965:Receptors, Glucocorticoid / Q000819:agonists / Q000235:genetics; D018161:Receptors, Mineralocorticoid / Q000819:agonists / Q000235:genetics
D005938:Glucocorticoids; D007527:Isoenzymes; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D018161:Receptors, Mineralocorticoid; D000450:Aldosterone; D003907:Dexamethasone; D043209:11-beta-Hydroxysteroid Dehydrogenase Type 2; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases; D003345:Corticosterone